시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 휴먼 마이크로칩핑 시장 보고서(2025년)
Human Microchipping Global Market Report 2025
상품코드 : 1691892
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 200 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,498,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,393,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,288,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 휴먼 마이크로칩핑 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년까지 연평균 성장률(CAGR) 7.4%, 26억 4,000만 달러로 성장할 것으로 추정됩니다. 예측기간의 성장은 신흥기술과의 통합, 마이크로칩과 헬스케어 시스템과의 통합 증가, 원활하고 편리한 결제 방법에 대한 수요 증가, 마이크로칩 기술의 채용 증가, 스마트 시티 인프라 개발 등에 기인한다고 생각됩니다. 예측 기간의 주요 동향으로는 생체 인증 강화, 웨어러블 디바이스 및 의료용 임플란트에 내장된 마이크로칩, 증강현실과의 통합, 환경 지속가능성, 맞춤형 의료 등이 있습니다.

비접촉형 거래 수요가 높아지는 것은 휴먼 마이크로칩핑 시장의 향후 성장을 가속할 것으로 예상됩니다. 예를 들어, 호주에 본사를 둔 독립 비교 사이트 Finder.com이 2023년 7월에 발표한 보고서에 따르면, 2022년에는 기본 추정 93%의 영국인이 온라인 뱅킹을 이용하고 있으며, 2023년에는 530만명(10%)의 영국인이 디지털 전용 은행 계좌를 개설할 의향을 나타내고 있습니다. 또한, 디지털 전용 은행 계좌의 보유자수는 2026년까지 2,260만명(43%)이 될 것으로 예측되고 있습니다.

휴먼 마이크로칩핑 시장의 주요 기업은 브레인 컴퓨터 인터페이스(BCI) 기능을 강화하고, 원활한 인간과 기계의 커뮤니케이션을 촉진하고, 이동에 어려움을 겪는 사람들을 위한 신경 보철 장치를 개선하기 위해 뉴런 스파이크 검출 등의 기술을 추진하고 있습니다. 뉴런 스파이크 검출은 뉴런이 생성하는 전기 신호를 인식하고 분석하고 뇌 활동을 이해하고 BCI 성능을 향상시키는 데 필수적입니다. 2024년 1월, BCI 기술에 특화된 미국 하이테크 기업 Neuralink Corporation는 인간용 브레인 컴퓨터 인터페이스 "Telepathy"를 발표했습니다. 이 무선 장치에는 칩과 대뇌 피질에 내장 된 1,000 개 이상의 초박형 유연한 전극 어레이가 포함되어 있습니다. Telepathy의 주요 특징은 신경 세포의 스파이크 검출, 무선 기능, 낮은 침습 사용을 위한 유연한 전극 설계, 정밀한 로봇 이식 등이며, 이들 모두 심각한 장애를 가진 사람의 커뮤니케이션 강화를 지원하도록 설계되었습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

JHS
영문 목차

영문목차

Human microchipping refers to a process that involves the implantation of microscopic integrated circuits, typically under the skin, to serve various purposes. The utilization of human microchipping offers advantages such as seamless access to health information during emergencies, automated management of devices, and enhanced convenience in everyday activities.

The main types of human microchips are implantable microchips and non-implantable microchips. Implantable microchips refer to electronic devices that are implanted subcutaneously (under the skin) in humans or animals. Various types of technologies are included, such as RFID (radio frequency identification), NFC (near-field communication), and others. These are used for various applications, including medical identification and monitoring, personal identification and access control, financial transactions, and others, by several end users, such as healthcare, financial services, retail and logistics, government and law enforcement, and others.

The main types of human microchips are implantable microchips and non-implantable microchips. Implantable microchips refer to electronic devices that are implanted subcutaneously (under the skin) in humans or animals. Various types of technologies are included, such as RFID (radio frequency identification), NFC (near-field communication), and others. These are used for various applications, including medical identification and monitoring, personal identification and access control, financial transactions, and others, by several end users, such as healthcare, financial services, retail and logistics, government and law enforcement, and others.

The human microchipping market size has grown strongly in recent years. It will grow from $1.85 billion in 2024 to $1.99 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to breakthroughs in semiconductor technology and miniaturization, rising concerns about identity theft, data breaches, and unauthorized access, increasing demand for medical implants and devices, companies started exploring microchipping as a means of employee identification and access control, regulatory approval.

The human microchipping market size is expected to see strong growth in the next few years. It will grow to $2.64 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to integration with emerging technologies, increased integration of microchips with healthcare systems, growing demand for seamless and convenient payment methods, increasing adoption of microchipping technology, the development of smart city infrastructure. Major trends in the forecast period include enhanced biometric authentication, microchips embedded in wearable devices and medical implants, augmented reality integration, environmental sustainability, personalized healthcare.

The growing demand for contactless transactions is expected to propel the growth of the human microchipping market going forward. Contactless transactions refer to a safe way of making a purchase when the seller's point-of-sale (POS) terminal and the buyer's card don't have to come into direct contact. The COVID-19 pandemic significantly accelerated the adoption of contactless payments due to heightened concerns about hygiene and germ transmission. Human microchipping is used in contactless or digital payments using near-field communication (NFC) or radio-frequency identification (RFID) technology. Contactless payments can be made possible by implanting these microchips into a person's hand or other bodily part. For instance, in July 2023, according to a report shared by Finder.com, an Australia-based independent comparison website, an estimated 93% of Brits were using online banking in 2022 and another 5.3 million Brits (10%) intend to get a digital-only bank account in 2023. Further, the number of digital-only bank account holders is predicted to be 22.6 million (43%) by 2026. Therefore, the growing demand for contactless transactions is driving the growth of the human microchipping market.

Leading companies in the human microchipping market are advancing technologies like neuron spike detection to boost brain-computer interface (BCI) functionality, foster seamless human-machine communication, and improve neuroprosthetic devices for people with mobility challenges. Neuron spike detection is essential for recognizing and analyzing the electrical signals generated by neurons, advancing our understanding of brain activity and enhancing BCI performance. For example, in January 2024, Neuralink Corporation, a U.S.-based tech firm focused on BCI technology, introduced Telepathy, a human brain-computer interface. This wireless device includes a chip and over 1,000 ultra-thin, flexible electrode arrays implanted into the cerebral cortex. Telepathy detects neuronal activity related to movement, converting these neural signals into computer commands to enable thought-based communication at high speeds. Key features of Telepathy include neuron spike detection, wireless capability, a flexible electrode design for minimally invasive use, and precise robotic implantation, all designed to support enhanced communication for individuals with severe disabilities.

In December 2022, Cantaloupe Inc., a US-based technology company, acquired Three Square Market for $4 million. With this acquisition, Cantaloupe will enhance its position in the micro market industry by offering comprehensive service capabilities. Additionally, the acquisition leads to an immediate expansion of Cantaloupe's global reach, enabling the company to introduce its full range of products to new international markets. Three Square Market is a US-based provider of human microchipping and implanted microchips.

Major companies operating in the human microchipping market are Johnson Controls International PLC, Texas Instruments Inc., STMicroelectronics N.V., NXP Semiconductors, Xerox Corporation, ARM Holdings Plc, Neuralink Corporation, Kaspersky Lab, Cherry Biotech SAS, VivoKey Technologies, Avid Identification Systems Inc., EpiCenter, Micronit Microtechnologies B.V., Applied Digital Solutions, Grindhouse Wetware, Dangerous Things LLC, Digiwell, Baja Beach Club, BioTeq Ltd., Somark Innovations, Walletmor Ltd., Chip AG, Biohax International AB, VeriChip Corporation

North America was the largest region in the human microchipping market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human microchipping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the human microchipping market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The human microchipping market consists of revenues earned by entities by providing services such as microchip implantation, integration, data management, and research and development. The market value includes the value of related goods sold by the service provider or included within the service offering. The human microchipping market also includes sales of syringes, RFID (Radio Frequency Identification) devices, silicate glass, bio-safe encasement, and antenna wire coils. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Human Microchipping Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on human microchipping market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for human microchipping ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The human microchipping market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Human Microchipping Market Characteristics

3. Human Microchipping Market Trends And Strategies

4. Human Microchipping Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Human Microchipping Growth Analysis And Strategic Analysis Framework

6. Human Microchipping Market Segmentation

7. Human Microchipping Market Regional And Country Analysis

8. Asia-Pacific Human Microchipping Market

9. China Human Microchipping Market

10. India Human Microchipping Market

11. Japan Human Microchipping Market

12. Australia Human Microchipping Market

13. Indonesia Human Microchipping Market

14. South Korea Human Microchipping Market

15. Western Europe Human Microchipping Market

16. UK Human Microchipping Market

17. Germany Human Microchipping Market

18. France Human Microchipping Market

19. Italy Human Microchipping Market

20. Spain Human Microchipping Market

21. Eastern Europe Human Microchipping Market

22. Russia Human Microchipping Market

23. North America Human Microchipping Market

24. USA Human Microchipping Market

25. Canada Human Microchipping Market

26. South America Human Microchipping Market

27. Brazil Human Microchipping Market

28. Middle East Human Microchipping Market

29. Africa Human Microchipping Market

30. Human Microchipping Market Competitive Landscape And Company Profiles

31. Human Microchipping Market Other Major And Innovative Companies

32. Global Human Microchipping Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Human Microchipping Market

34. Recent Developments In The Human Microchipping Market

35. Human Microchipping Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기